Multiple endocrine neoplasia, type 2 (MEN 2): Drugs containing semaglutide carry a boxed warning for MEN 2
Cost considerations Pharmaceutical semaglutide (Wegovy): $1,300-1,500/month without insurance Insurance may cover (varies) Patient assistance programs available Research semaglutide: $150-300/month No insurance No patient assistance User assumes risk Research cagrilintide: $200-400/month Not prescription available yet Higher cost due to limited availability Total CagriSema combination cost (research chemicals): $350-700/month Both peptides at full dose Significant investment Compare to bariatric surgery ($15,000-25,000 upfront) Budget planning: Year 1 (titration + maintenance): $4,200-8,400 Ongoing maintenance: $350-700/month Consider reducing to maintenance doses May need 12-24+ months total Use our peptide cost calculator to budget protocols
Sirtuin-1 and its relevance in vascular calcification
Protocols vary, but a typical approach tends to involve 35 sessions spaced 24 weeks apart, often combined with other treatment modalities
Common side effects include nausea, constipation, and fatigue, particularly during dose escalation
And B12 isnt likely to boost energy unless youre deficient
